Join us for an engaging discussion with a leading hematologist about the treatment of hemophilia B, an actual patient case study, and a clinical overview of IDELVION.
CSL Behring is committed to providing treatments and support services that make a meaningful difference in the lives of people with bleeding disorders.
Resources are available to help your patients get the treatment they need for hemophilia B, including:
References: 1. Hemophilia FIX Market Assessment, Third-Party Market Research. 2. Gill JC, Roberts J, Li Y, Castaman G. Sustained high trough factor IX activity levels with continued use of rIX-FP in adult and paediatric patients with haemophilia B. Haemophilia. 2019. doi:10.1111/hae.13735.